|

Palmaris Longus Muscle and Dupuytren

RECRUITINGN/ASponsored by Universitaire Ziekenhuizen KU Leuven
Actively Recruiting
PhaseN/A
SponsorUniversitaire Ziekenhuizen KU Leuven
Started2024-02-16
Est. completion2025-06-01
Eligibility
Age50 Years+
Healthy vol.Accepted

Summary

Dupuytren disease is a medical condition characterized by the painless formation of nodules in the palm of the hand. Cords are formed on the palmar fascia, a connective tissue sheet in the palm of the hand. This fascia is seen as the vestigial remnant of the palmaris longus tendon. The PLM attaches to the fascia palmaris. A muscle that not everyone has and can therefore be clearly missed. This raises the question of whether the presence of the musculus palmaris longus has any association with the development, recurrence and/or progression of DD and contractures. To investigate a potential predisposition, this study intend to assess the prevalence of the PLM in a group of individuals affected by DD and compare it with a control group (age matched, no signs of DD) without the condition.

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* The participant or his/her legally authorized representative voluntary signed the informed consent prior to the first assessment.
* 50 years of age or higher.
* Has Dupuytren disease (primary or recurrent). (Only applicable for participants of DD group)
* Has no medical conditions affecting the function of the hand (musculoskeletal pathology, vascular or neurological conditions such as CRPS, rheumatoid arthritis and paralysis). (Only applicable for participants of control group)

Exclusion Criteria:

* Patients \< 50 years
* Patients with cognitive impairments.
* Patients showing signs of medical conditions affecting the function of the hand (musculoskeletal pathology, vascular or neurological conditions such as CRPS, rheumatoid arthritis and paralysis). (Only applicable for participants of control group)

Conditions2

CancerDupuytren's Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.